Breakthrough in Understanding Inflammatory Bowel Disease
August 02, 2024
August 02, 2024
NEWCASTLE UPON TYNE, England, Aug. 2 (TNSres) -- Newcastle University issued the following news:
A pioneering study has identified a new disease-inducing mechanism for inflammatory bowel disease (IBD) in which the immune system attacks its own regulatory function.
Interleukin-10 (IL10) is an anti-inflammatory protein that crucially controls intestinal immunity. Children with genetic defects in IL10, or its receptors, suffer from a severe form of IBD that typically prese . . .
A pioneering study has identified a new disease-inducing mechanism for inflammatory bowel disease (IBD) in which the immune system attacks its own regulatory function.
Interleukin-10 (IL10) is an anti-inflammatory protein that crucially controls intestinal immunity. Children with genetic defects in IL10, or its receptors, suffer from a severe form of IBD that typically prese . . .